Status:
COMPLETED
A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
Lead Sponsor:
Centocor, Inc.
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if infliximab (anti-TNF) is effective in the treatment of plaque psoriasis.
Detailed Description
This is an experimental medical research study. The purpose of this study is to determine if infliximab is effective in the treatment of plaque psoriasis. A total of about 375 patients primarily in Eu...
Eligibility Criteria
Inclusion
- Patients who have had a diagnosis of plaque-type psoriasis for at least 6 months
- Patients who have plaque-type psoriasis covering at least 10% of the body
Exclusion
- Patients must not have nonplaque forms of psoriasis
- Patients must not have current drug-induced psoriasis
- Patients must not be pregnant, nursing, or planning pregnancy (both men and women) within 18 months of enrollment
- Patients must not have had any previous treatment with infliximab or any therapeutic agent targeted at reducing TNF
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
378 Patients enrolled
Trial Details
Trial ID
NCT00106834
End Date
October 1 2004
Last Update
May 19 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.